Home›Companies›Healthcare›SalivIQ Diagnostics

SalivIQ Diagnostics Inc.

Develops a saliva-based strep throat test for clinicians and patients.

Updated Nov 9, 2026·Latest SEC filing Sep 23, 2026·Suggest an edit

About SalivIQ Diagnostics

SalivIQ Diagnostics is a private company based in Harrisonburg, Virginia, incorporated in 2024 in Delaware. It has reported $1,911,999 raised in one offering on Form D since June 2026. Its chief executive is Julia Halterman.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 26, 2026Jun 10, 2026amended Sep 23, 2026$1,911,999of $3.1M target50$38,240EquityRule 506(b)Form D/A ↗1 earlier filing

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on SalivIQ Diagnostics's Form D filed Sep 23, 2026.

JH
Julia Halterman
Founder & CEO, director
GB
Gregory Bell
Board Member

Sources

  1. SECSalivIQ Diagnostics Inc. Form D, filed Jun 10, 2026
  2. SECSalivIQ Diagnostics Inc. filing history
  3. CompanyTerms and Conditions
  4. CompanyAbout Us
  5. CompanySeed Round Closing